List view / Grid view
8 December 2011 | By Abbott
Abbott today announced the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial...
8 December 2011 | By Roche
6.1 month improvement in median progression free survival, from 12.4 to 18.5 months...
8 December 2011 | By Johnson & Johnson
Compound in development for multiple B-cell hematologic malignancies...
8 December 2011 | By Novartis
Updated results of a Phase III study...
7 December 2011 | By kdm communications limited
Syrris is pleased to announce the release of its new batch chemistry reactors catalogue...
6 December 2011 | By kdm communications limited
Infinite M1000 PRO is Tecan’s latest generation high-end multimode microplate reader...
6 December 2011 | By Merck Millipore
Experts from around the world share perspectives and insights on topics related to process-scale chromatography...
6 December 2011 | By MSD
Data presented at the IDF 21st World Diabetes Congress...
6 December 2011 | By Novo Nordisk
Insulin degludec / insulin aspart reduced rates of hypoglycaemia by 58%...
6 December 2011 | By
Commits $1.5 billion to R&D in China over the next 5 years...
6 December 2011 | By Sanofi
Data from phase III GetGoal Duo 1 study...
5 December 2011 | By http://www.bis.gov.uk/newsroom
Three million at-risk patients to receive hi-tech equipment in the home - part of a series of measures outlined by the Prime Minister today to support the UK’s life sciences industry...
5 December 2011 | By GlaxoSmithKline
"The Government’s strategy for Life Sciences is a very important next step on the journey..."
5 December 2011 | By Biogen Idec
Samsung and Biogen Idec announced that they have entered into an agreement to invest $300 million to establish a joint venture to develop, manufacture and market biosimilars...
5 December 2011 | By Novo Nordisk
New data from the A1chieve® study...
